Offer - Urjas Oil for just ₹ 1 X
Ethambutol + Isoniazid + Rifampicin is an allopathic medicine Secondary and off-label uses of Ethambutol + Isoniazid + Rifampicin have also been mentioned below. The correct dosage of Ethambutol + Isoniazid + Rifampicin depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Ethambutol + Isoniazid + Rifampicin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Ethambutol + Isoniazid + Rifampicin is used -
Common
Is the use of Ethambutol + Isoniazid + Rifampicin safe for pregnant women?
Pregnant women may experience moderate side effects from Ethambutol + Isoniazid + Rifampicin. It is best to stop taking Ethambutol + Isoniazid + Rifampicin immediately and inform your doctor if you notice any discomfort.
Is the use of Ethambutol + Isoniazid + Rifampicin safe during breastfeeding?
Side effects of Ethambutol + Isoniazid + Rifampicin on breastfeeding women are very mild.
What is the effect of Ethambutol + Isoniazid + Rifampicin on the Kidneys?
There can be some harmful effects on your kidneys after taking Ethambutol + Isoniazid + Rifampicin. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Ethambutol + Isoniazid + Rifampicin on the Liver?
Ethambutol + Isoniazid + Rifampicin can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ethambutol + Isoniazid + Rifampicin on the Heart?
Side effects of Ethambutol + Isoniazid + Rifampicin rarely affect the heart.
Ethambutol + Isoniazid + Rifampicin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Mild
If you are suffering from any of the following diseases, you should not take Ethambutol + Isoniazid + Rifampicin unless your doctor advises you to do so -
Is this Ethambutol + Isoniazid + Rifampicin habit forming or addictive?
Yes, Ethambutol + Isoniazid + Rifampicin cause dependence in some cases. Talk to your doctor before taking it.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Ethambutol + Isoniazid + Rifampicin. So it is best to avoid driving.
Is it safe?
Yes, Ethambutol + Isoniazid + Rifampicin is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Ethambutol + Isoniazid + Rifampicin in mental disorders is not effective.
Interaction between Food and Ethambutol + Isoniazid + Rifampicin
When consumed with certain foods, Ethambutol + Isoniazid + Rifampicin may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Ethambutol + Isoniazid + Rifampicin
Side effects of drinking alcohol and taking Ethambutol + Isoniazid + Rifampicin at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Myambutol (ethambutol hcl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 535-536
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768